PPT-Access to medicines and health technologies for NCDs

Dr Cécile Macé WHO EMP Mr ArnePetter Sanne WHO MND Mr Ajuebor Onyema WHO MND NCD Programme Managers Seminar 4 June 2014 Access to NCD essential medicines on the global agenda. Noncommunicable Diseases –Action Plan . . Dr Shanthi Mendis . Director, Department of NCD Management a.i.. World Health Organization. Geneva, Switzerland. Dr. Christopher . Tufton. Hon. Minister of Health, Jamaica. NCDs : Burden in The Caribbean. 3 out of 4 people die from an NCD. NCDs: Caribbean Highest Premature Mortality. Premature Mortality:. –. lessons from HIV. EPIP, 5 September 2017, Bordeaux. . Ellen ‘t Hoen, LLM. University Medical Centre Groningen, Global Health Unit. @. ellenthoen. www.medicineslawandpolicy.org. Brief history. Stops AIDS National Gathering . 1st November 2014. Aliénor Devali. ère. Health. Action International (HAI) Europe. This document arises from HAI Europe’s Operating Grant 2014, which has received funding from the . WHO EMP and NVI Departments. Access to NCD essential medicines . on the global agenda. Access to chronic disease medicines is required for the fulfilment of MDG8. Governments, in collaboration with the private sector, should give greater priority to treating chronic diseases and improving the accessibility of medicines to treat them (MDG Report 2009). Development. Esteban Burrone. Head of Policy. Medicines. Patent Pool. Collaboration to promote innovation and . aCCESS. TO MEDICINES. Innovation. and . Access. are two sides of the same coin and central to ensuring improvements in public health outcomes worldwide. Access to medicines and technologies. Report . to the WHA 69. th. . on. . “Addressing the global shortages of medicines and the safety and accessibility of children’s . medication”. . (Doc A69/42. Strategic Plan Development – . Feed-back from the WHA 67. th. . IPC Meeting. WHO Geneva, June 04 - 06. WHO medicines & technologies 2014-2019 strategy / action plan. GPW : 6 leadership priorities . Access to medicines and technologies. Report . to the WHA 69. th. . on. . “Addressing the global shortages of medicines and the safety and accessibility of children’s . medication”. . (Doc A69/42. Strategic Plan Development – . Feed-back from the WHA 67. th. . IPC Meeting. WHO Geneva, June 04 - 06. WHO medicines & technologies 2014-2019 strategy / action plan. GPW : 6 leadership priorities . Access to medicines and technologies. Report . to the WHA 69. th. . on. . “Addressing the global shortages of medicines and the safety and accessibility of children’s . medication”. . (Doc A69/42. Noncommunicable Diseases –Action Plan . . Dr Shanthi Mendis . Director, Department of NCD Management a.i.. World Health Organization. Geneva, Switzerland. R 5 Nwwwnaturecom/cptnature publishing groupSTATE ARTere is consensus among stakeholderspatients providers academic researchers regulators health technology assess-ment HTA bodies/payers who Dr. Richard Torbett. Chief Economist, EFPIA. China/ EU Pharmaceutical Industry Forum. Shanghai, . 16 May 2015. Policy debate on health in recent years has been dominated by cost containment. Health & Growth.